Robert M.Davis is Chief executive officer and president of Merck.
Rob joined the company as chief financial officer in 2014 with additional responsibility for real estate operations, corporate strategy and business development.
Prior to joining Merck, Rob was corporate vice president and president of Baxter’s Medical Products business. During his tenure at Baxter, he held several other positions, including president of Baxter’s Renal business, chief financial officer and treasurer. Before joining Baxter in 2004, Rob held numerous positions of increasing responsibility over 14 years at Eli Lilly and Company..
He received his J.D. from North-western University School of Law, his M.B.A. from North-western University’s Kellogg Graduate School of Management and his bachelor’s degree in finance from Miami University.